Company Registration No. SC728731 (Scotland)
TARGET PHARMACEUTICALS LIMITED
PREVIOUSLY KNOWN AS TARGET HEALTHCARE INTERNATIONAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
TARGET PHARMACEUTICALS LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2
Notes to the financial statements
3 - 4
TARGET PHARMACEUTICALS LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr L Campbell
Mr S Duncan
Mrs G Grant
Company number
SC728731
Registered office
8 Redwood Crescent
East Kilbride
United Kingdom
G74 5PA
Accountants
Consilium Chartered Accountants
169 West George Street
Glasgow
Scotland
G2 2LB
TARGET PHARMACEUTICALS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2023
31 December 2023
- 2 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
3
1
1
Net current assets
1
1
Capital and reserves
-
-
Called up share capital
4
1
1
For the financial year ended 31 December 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 31 May 2024 and are signed on its behalf by:
Mrs G Grant
Director
Company Registration No. SC728731
TARGET PHARMACEUTICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
- 3 -
1
Accounting policies
Company information
Target Pharmaceuticals Limited is a private company limited by shares incorporated in Scotland. The registered office is 8 Redwood Crescent, East Kilbride, United Kingdom, G74 5PA. The company's registration number is SC728731.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Profit and loss account
The company has not traded during the year. During the year, the company received no income and incurred no expenditure and therefore no profit and loss account is presented in these financial statements.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2023
2022
Total
3
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
1
1
4
Called up share capital
2023
2022
£
£
Ordinary share capital
Issued and fully paid
1 Ordinary shares of £1
1
1
TARGET PHARMACEUTICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 4 -
5
Ultimate controlling party
The Company is a wholly owned subsidiary of Target Healthcare Group Limited. The company is included within the consolidated financial statements of Target Healthcare Group Limited, available at the registered address 8 Redwood Crescent, East Kilbride, Glasgow, Scotland, G74 5PA.
The ultimate parent company is Target Healthcare Group Limited, a company registered in the Isle of Man. No consolidated accounts are required at this level.
The ultimate controlling party is L Campbell.